Fiche société
Brise Pharmaceuticals Co., Ltd.
Traitements, essais et publications liés.
Traitements3programmes
Essais2liés
Publications0liées
SourceDBlocale
Traitements
3| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| BR005-036CThe purpose of this study is to compare the efficacy and safety of BR005-036C versus placebo in subjects with Acute Migraines | Migraine | Phase 3 | À vérifier | China | À vérifier |
| BR005-036CThe purpose of this study is to compare the efficacy and safety of BR005-036C versus placebo in subjects with Acute Migraines | Migraine | Phase 2/3 | À vérifier | China | À vérifier |
| BR005-036CThe purpose of this study is to compare the efficacy and safety of BR005-036C versus placebo in subjects with Acute Migraines | Migraine | Phase 3 | À vérifier | China | À vérifier |
Essais cliniques
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| BR005-036C | Migraine | Phase 3 | NCT07835152 | Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults | NOT_YET_RECRUITING |
| BR005-036C | Migraine | Phase 2/3 | NCT07792681 | Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults | RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||